About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5426706
Allelic
Composition		 Nr1d1tm1.1Rev/Nr1d1tm1.1Rev
Nr1d2tm1.1Rev/Nr1d2tm1.1Rev
Tg(CAG-cre/Esr1*)5Amc/0
Genetic
Background		 involves: BALB/cJ * C57BL/6 * C57BL/6J * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr1d1tm1.1Rev mutation (0 available); any Nr1d1 mutation (40 available)
Nr1d2tm1.1Rev mutation (0 available); any Nr1d2 mutation (25 available)
Tg(CAG-cre/Esr1*)5Amc mutation (9 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
homeostasis/metabolism
decreased circulating glucose level ( J:183855 )
• in tamoxifen-treated mice
increased circulating free fatty acids level ( J:183855 )
• in tamoxifen-treated mice
decreased circulating triglyceride level ( J:183855 )
• in tamoxifen-treated mice
decreased respiratory quotient ( J:183855 )
• in tamoxifen-treated mice

behavior/neurological
shortened circadian behavior period ( J:183855 )
• shortened and fragmented activity period in tamoxifen-treated mice

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
06/12/2024
MGI 6.13 		The Jackson Laboratory